retatrutide clinical trial dose weight loss data Results: 24% in 48 Weeks Retatrutide dose: the complete guide – The Retatrutide Dosage Chart

SURMOUNT-5 is the only direct head-to-head trial among the three

Harvard Health Publishing explains that muscle tissue influences resting metabolic rate, meaning it affects how many calories your body uses at rest. Preserving muscle during weight loss helps support physical function and makes long-term weight maintenance more achievable

Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, and Butler PC

Phase 2 Confirmatory Dosing Data Phase 3 Standardized Dosing Regimens Current phase 3 trials employ standardized retatrutide dosing protocols: Retatrutide Dosing: Titration Protocols for Optimal Outcomes Standard Clinical Titration Schedule Gradual escalation is the cornerstone of safe retatrutide dosing : Accelerated Titration for Tolerant Subjects Conservative Titration for Sensitive Populations Retatrutide Dosing: Species-Specific Preclinical Protocols Mouse Models Allometric scaling consideration : Mouse retatrutide dosing at 0.3 mg/kg produces approximately human-equivalent exposure to 12 mg weekly when adjusted for metabolic rate and body surface area